PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
21-Jul-2022 Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing Navigo Proteins GmbH
20-Jul-2022 A new measure of psychological safety for patients University of Strathclyde
20-Jul-2022 ALLIANCE PHARMA Half Year Trading Update ALLIANCE PHARMA
20-Jul-2022 Almirall launches new call to find innovative therapies for skin diseases Almirall
20-Jul-2022 Resolution Therapeutics Appoints Dr. Bill Symonds to its Board of Directors Resolution Therapeutics
19-Jul-2022 AARDEX® Group and BIOCORP Recruited by Trials@Home - Decentralized Clinical Trial Centre of Excellence AARDEX® Group
19-Jul-2022 Bone Therapeutics optimizes statistical analysis and introduces interim analysis in the ongoing ALLOB Phase IIb study for high-risk tibial fractures Bone Therapeutics
19-Jul-2022 Destiny Pharma announces positive update from US FDA on XF-73 Phase 3 development plans Destiny Pharma
18-Jul-2022 Novotech and Endpoints Present "Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T" Novotech Health Holdings Pte Ltd
18-Jul-2022 TrialWire Technology Platform Announces Success-based Patient Recruitment Plan TrialWire
15-Jul-2022 Growing Elderly Population Leads to Benign Prostatic Hyperplasia Treatment Market Expansion P&S Intelligence
14-Jul-2022 Brits have worst mental health in Europe, STADA Health Report 2022 reveals The STADA Group
14-Jul-2022 PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate PureTech Health plc
14-Jul-2022 TANIOBIS invests in new test and production plant for chlorides TANIOBIS
14-Jul-2022 83% fewer vaccinated women hospitalised during pregnancy – but only Omicron jab can maintain success New Office for National Statistics
14-Jul-2022 Nanoform and Pharmanovia to breathe new life into iconic medicines Nanoform Finland Plc
14-Jul-2022 Grünenthal acquires testosterone treatment Nebido™ from Bayer Bayer
14-Jul-2022 Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis Sanofi
14-Jul-2022 Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0% Prophecy Market Insights
13-Jul-2022 Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea Novotech Health Holdings Pte Ltd